WELCURE DRUG Fact Sheet, WELCURE DRUG Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WELCURE DRUG Fact Sheet    (WEDG)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of WELCURE DRUG. For more details, see the WELCURE DRUG quarterly results and WELCURE DRUG share price and chart. For a sector overview, read our pharmaceuticals sector report.

WELCURE DRUG Price History

Price Rs 7.6
Mkt Cap Rs m 103
Vol '000 21.6
P/E X 395.5
P/CF X 186.6
EPS (TTM) Rs 0.0
% ch % 5.0
No. of shares m 13.51
% ch week % 26.0
% ch 1-mth % 6.6
% ch 12-mth % 273.0
52 week H/L Rs 10.5/1.9
(As on Sep 21, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WELCURE DRUG Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
WELCURE DRUG EQUITY SHARE DATA
High Rs54112 
Low Rs111NANA 
Sales per share (Unadj.) Rs0.100.10.10.1 
Earnings per share (Unadj.) Rs00000 
Diluted earnings per shareRs0.00.00.00.00.0 
Cash flow per share (Unadj.) Rs00000 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs00000.1 
Adj. book value per shareRs0.00.00.00.00.1 
Shares outstanding (eoy) m13.5113.5113.5113.5113.51 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x43.468.116.18.113.5 
Avg P/E ratio x141.3-174.6320.9-70.432.7 
P/CF ratio (eoy) x141.3-174.6320.9-70.432.7 
Price / Book Value ratio x99.0172.454.146.925.9 
Dividend payout %00000 
Avg Mkt Cap Rs m393413718 
No. of employees `000NANANANANA 
Total wages/salary Rs m00000 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
WELCURE DRUG INCOME DATA
Net Sales Rs m11111 
Other income Rs m00000 
Total revenues Rs m11111 
Gross profit Rs m00001 
Depreciation Rs m00000 
Interest Rs m00000 
Profit before tax Rs m00001 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m00000 
Profit after tax Rs m00001 
Gross profit margin %30.7-41.02.9-11.641.4 
Effective tax rate %00000 
Net profit margin %30.6-38.84.9-11.341.4 
WELCURE DRUG BALANCE SHEET DATA
Current assets Rs m00001 
Current liabilities Rs m00000 
Net working cap to sales %43.539.629.617.252.2 
Current ratio x10.85.85.02.518.3 
Inventory Days Days00000 
Debtors Days Days00000 
Net fixed assets Rs m00000 
Share capital Rs m121121121121121 
"Free" reserves Rs m-121-121-121-121-120 
Net worth Rs m00001 
Long term debt Rs m00000 
Total assets Rs m00001 
Interest coverage xNMNMNMNMNM 
Debt to equity ratio x00000 
Sales to assets ratio x2.12.22.73.31.8 
Return on assets %64.3-83.913.2-37.275.6 
Return on equity %70.7-97.016.2-67.179.9 
Return on capital %70.9-96.516.5-66.480.0 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m00000 
Net fx Rs m00000 
WELCURE DRUG CASH FLOW
From Operations Rs m 0 0 0 0 0 
From Investments Rs m 0 0 0 0 0 
From Financial Activity Rs m 0 0 0 0 0 
Net Cashflow Rs m 0 0 0 0 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 14.1%
Institution 0.0%
Non-Institution 85.9%
Total 100.0%
Free Float 85.9%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF B-9 & 10 Laxmi Towers, L. S. C. C Block, Saraswati Vihar, Delhi - 100034
E-MAIL investor.welcure@gmail.com WEB
TEL FAX
SECTOR TRADING GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., Noble Heights 1st Floor Plot NH 2, C-1 Block LSC Near Savitri Market, Janakpuri
YEAR OF INC: 1996 BSE CODE: 524661 FV (Rs): 10 DIV YIELD (%): -

More Trading Company Fact Sheets:   LAURUS LABS   UNICHEM LAB  PARNAX LAB  ASTER DM HEALTHCARE  TRANS ASIA CORP  

Compare WELCURE DRUG With:   LAURUS LABS   UNICHEM LAB  PARNAX LAB  ASTER DM HEALTHCARE  TRANS ASIA CORP  




Today's Market

4 Reasons Why Sensex Surged 514 Points Today(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a strong note.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WELCURE DRUG

  • Track your investment in WELCURE DRUG with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WELCURE DRUG

WELCURE DRUG - GUJARAT COTEX COMPARISON

COMPARE WELCURE DRUG WITH

MARKET STATS